Sandoz Group AG (SDZNY OTCGREY) stock market data APIs
$92.9017
0.12(0.1%)
as of August 17, 2026
Try our APIs with
free plan!
Sandoz Group AG Financial Data Overview
Price chart is built with
Anychart
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Prev. Close
92.9017
Open
93.0181
High
93.9231
Low
92.7641
52 wk Range
54.7495-93.14
Market Cap
39 945 M
P/E Ratio
60.9801
Shares Outstanding
433 M
Revenue
11 676 M
Dividends (Yield)
0.0114
Beta
0.492
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sandoz Group AG (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sandoz Group AG data using free add-ons & libraries
Get Sandoz Group AG Fundamental Data
Sandoz Group AG Fundamental data includes:
- Net Revenue: 11 676 M
- EBITDA: 1 574 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sandoz Group AG News
New
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initi...
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initi...
Sandoz Group AG (SDZNY) (H1 2026) Earnings Call Highlights: Biosimilar Growth Drives 5% Sales ...
This article first appeared on GuruFocus. Net Sales: Increased by 5% at constant currencies in H1 2026, reaching US$5.8 billion, up from US$5.2 billion in H1 2025. Biosimilar Sales: Grew by 20% in H1...
Sandoz Group (SWX:SDZ) Settles US Drug Pricing Cases And Wins Brazil Semaglutide Approval
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Sandoz Group (SWX:SDZ) has agreed US settlements that resolve long running investigations i...
Get Sandoz Group AG fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
